Shneider BL, Brown MB, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148:467-474.
Bezerra JA, Spino C, Magee JC, et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014;311:1750-1759.
1. Ohi R, Masaki N. The jaundiced infant: biliary atresia and other obstructions. In: O'Neill JA, Rowe MI, Grosfeld JL, et al, eds. Pediatric surgery, 5th ed. St Louis, MO: Mosby; 1998:1465-1482.
2. Balistreri W. Liver disease in infancy and childhood. In: Schiff DF, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver. Philadelphia, PA: Lippincott-Raven; 1999:1357-1512.
3. Silveira TR, Salzano FM, Howard ER, et al. Congenital structural abnormalities in biliary atresia: evidence for etiopathogenic heterogeneity and therapeutic implications. Acta Paediatr Scand. 1991;80:1192-1199.
4. Karrer FM, Hall RJ, Lilly JR. Biliary atresia and the polysplenia syndrome. J Pediatr Surg. 1991;26:524-527.
5. Jacquemin E, Cresteil D, Raynaud N, et al. CFCI gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr. 2002;34:326-327.
6. Kataria R, Kataria A, Gupta DK. Spectrum of congenital anomalies associated with biliary atresia. Indian J Pediatr. 1996;63:651-654.
7. Casey B. Genetics of human situs abnormalities. Am J Med Genet. 2001;101:356-358.
8. Davenport M, Tizzard SA, Underhill J, et al. The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr. 2006;149:393-400.
9. Chardot C. Biliary atresia. Orphanet J Rare Dis. 2006;1:28.
10. Wang SH, Chen CL, Concejero A, et al. Living donor liver transplantation for biliary atresia. Chang Gung Med J. 2007;30:103-108.
11. Wada H, Muraji T, Yokoi A, et al. Insignificant seasonal and geographical variation in incidence of biliary atresia in Japan: a regional survey of over 20 years. J Ped Surg. 2007;42:2090-2092.
12. Tiao MM, Tsai SS, Kuo HW, et al. Epidemiological features of biliary atresia in Taiwan, a national study 1996-2003. J Gastroent Hepatol. 2008;23:62-66.
13. Schreiber RA, Kleinman RE. Genetics, immunology, and biliary atresia: an opening or a diversion? J Pediatr Gastroenterol Nutr. 1993;16:111-113.
14. Yoon PW, Bresee JS, Olney RS, et al. Epidemiology of biliary atresia: a population-based study. Pediatrics. 1997;99:376-382.
15. Sokol RJ, Mack C, Narkewicz MR, et al. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr. 2003;37:4-21.
16. Ayas MF, Hillemeier AC, Olson AD. Lack of evidence for seasonal variation in extrahepatic biliary atresia during infancy. J Clin Gastroenterol. 1996;22:292-294.
17. Caton AR, Druschel CM, McNutt LA. The epidemiology of extrahepatic biliary atresia in New York State, 1983-98. Paediatr Perinat Epidemiol. 2004;18:97-105.
18. Smith BM, Laberge JM, Schreiber R, et al. Familial biliary atresia in three siblings including twins. J Pediatr Surg. 1991;26:1331-1333.
19. Morecki R, Glaser JH, Cho S, et al. Biliary atresia and reovirus type 3 infection. N Engl J Med. 1984;310:1610.
20. Morecki R, Glaser JH, Cho S, et al. Biliary atresia and reovirus type 3 infection. N Engl J Med. 1982;307:481-484.
21. Morecki R, Glaser JH, Johson AB, et al. Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study. Hepatology. 1984;4:1137-1142.
22. Glaser JH, Balistreri WF, Morecki R. Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr. 1984;105:912-915.
23. Brown WR, Sokol RJ, Levin MJ, et al. Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr. 1988;113:670-676.
24. Bangaru B, Morecki R, Glaser JH, et al. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest. 1980;43:456-462.
25. Stanley NF, Joske RA. Animal model of human disease. Chronic biliary obstruction. Animal model: chronic biliary obstruction caused by reovirus type 3. Am J Pathol. 1975;80:185-188.
26. Rosenberg DP, Morecki R, Lollini LO, et al. Extrahepatic biliary atresia in a rhesus monkey (Macaca mulatta). Hepatology. 1983;3:577-580.
27. Tyler KL, Sokol RJ, Oberhaus SM, et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology. 1998;27:1475-1482.
28. Steele MI, Marshall CM, Lloyd RE, et al. Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology. 1995;21:697-702.
29. Lorent K, Gong W, Koo KA, et al. Identification of a plant isoflavonoid that causes biliary atresia. Sci Transl Med. 2015;7:286ra67.
30. Silveira TR, Salzano FM, Donaldson PT, et al. Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr. 1993;16:114-117.
31. Kobayashi, H, Puri P, O'Briain DS, et al. Hepatic overexpression of MHC class II antigens and macrophage associated antigens (CD68) in patients with biliary atresia of poor prognosis. J Pediatr Surg. 1997;32:590-593.
32. Hart MH, Kaufman SS, Vanderhoof JA, et al. Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins. Am J Dis Child. 1991;145:302-305.
33. Danesino C, Spadoni E, Buzzi A. Familial biliary atresia. Am J Med Genet. 1999;85:195.
34. Ando K, Miyano T, Fujimoto T, et al. Sibling occurrence of biliary atresia and biliary dilatation. J Pediatr Surg. 1996;31:1302-1304.
35. Cheng G, Tang CS, Wong EH, et al. Common genetic variants regulating ADD3 gene expression alter biliary atresia risk. J Hepatol. 2013;59:1285-1291.
36. Garcia-Barceló MM, Yeung MY, Miao XP, et al. Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum Mol Genet. 2010;19:2917-2925.
37. Pickett LK, Briggs HC. Biliary obstruction secondary to hepatic vascular ligation in fetal sheep. J Pediatr Surg. 1969;4:95-101.
38. Klippel CH. A new theory of biliary atresia. J Pediatr Surg. 1972;7:651-654.
39. Ho CW, Shioda K, Shirasaki K, et al. The pathogenesis of biliary atresia: a morphological study of the hepatobiliary system and the hepatic artery. J Pediatr Gastroenterol Nutr. 1993;16:53-60.
40. Mack CL. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis. 2007;27:233-242.
41. Bezerra JA, Tiao G, Ryckman FC, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet. 2002;360:1653-1659.
42. Bezerra JA. The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia. J Pediatr Gastroenterol Nutr. 2006;43(suppl 1):S23-S29.
43. Russo P, Rand EB, Haber BA. Diseases of the biliary tree in infancy and childhood. In: Russo P, Ruchelli ED, Piccoli DA, eds. Pathology of pediatric gastrointestinal and liver disease. New York, NY: Springer; 2004:203-236.
44. Silveira TR, Salzano FM, Howard ER, et al. Extrahepatic biliary atresia and twinning. Braz J Med Biol Res. 1991;24:67-71.
45. Chardot C, Carton M, Spire-Bendelac N, et al. Epidemiology of biliary atresia in France: a national study 1986-96. J Hepatol. 1999;31:1006-1013.
46. Fischler B, Papadogiannakis N, Nemeth A. Aetiological factors in neonatal cholestasis. Acta Paediatr. 2001;90:88-92.
47. Humphrey TM, Stringer MD. Biliary atresia: US diagnosis. Radiology. 2007;244:845-851.
48. Park WH, Choi SO, Lee HJ, et al. A new diagnostic approach to biliary atresia with emphasis on the ultrasonographic triangular cord sign: comparison of ultrasonography, hepatobiliary scintigraphy, and liver needle biopsy in the evaluation of infantile cholestasis. J Paediatr Surg. 1997;32:1555-1559.
49. Azar G, Beneck D, Lane B, et al. Atypical morphologic presentation of biliary atresia and value of serial liver biopsies. J Pediatr Gastroenterol Nutr. 2002;34:212-215.
50. Zerbini MC, Gallucci SD, Maezono R, et al. Liver biopsy in neonatal cholestasis: a review on statistical grounds. Mod Pathol. 1997;10:793-799.
51. Lurie M, Elmalach I, Schuger L, et al. Liver findings in infantile cytomegalovirus infection: similarity to extrahepatic biliary obstruction. Histopathology. 1987;11:1171-1180.
52. Ishak KG. Inherited metabolic diseases of the liver. Clin Liver Dis. 2002;6:455-479,viii.
53. Deutsch GH, Sokol RJ, Stathos TH, et al. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome. Pediatr Dev Pathol. 2001;4:559-563.
54. Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition. J Pediatr. 1971;78:180-181.
55. Witzleben CL. Neonatal liver disease. Monogr Pathol. 1981;22:346-368.
56. Oppenheimer EH, Esterly JR. Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis. J Pediatr. 1975;86:683-689.
57. Shapira R, Hadzic N, Francavilla R, et al. Retrospective review of cystic fibrosis presenting as infantile liver disease. Arch Dis Child. 1999;81:125-128.
58. Lefkowitch JH. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and "cholangitis lenta." Hum Pathol. 1982;13:19-24.
59. Iinuma Y, Narisawa R, Iwafuchi M, et al. The role of endoscopic retrograde cholangiopancreatography in infants with cholestasis. J Pediatr Surg. 2000;35:545-549.
60. Norton KI, Glass RB, Kogan D, et al. MR cholangiography in the evaluation of neonatal cholestasis: initial results. Radiology. 2002;222:687-691.
61. Chen SM, Chang MH, Du JC, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics. 2006;117:1147-1154.
62. Maki T, Sumasaki R, Matsui A. Biliary atresia: recent findings. Mass screening for biliary atresia. Jpn J Pediatr Surg. 1999;31:242-246.
63. Mushtaq I, Logan S, Morris M, et al. Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. BMJ. 1999;319:471-477.
64. Schreiber RA, Barker CC, Roberts EA, et al. Biliary atresia: the Canadian experience. J Pediatr. 2007;151:659-665.
65. Shneider BL, Brown MB, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148:467-474.
66. Altman RP, Lilly JR, Greenfeld J, et al. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg. 1997;226:348-355.
67. National Institutes of Health. Consensus development conference statement: liver transplantation - June 20-23, 1983. Hepatology. 1984;4(1 suppl):107S-110S.
68. Barshes NR, Lee TC, Balkrishnan R, et al. Orthotopic liver transplantation for biliary atresia: the U.S. experience. Liver Transpl. 2005;11:1193-1200.
69. Petersen C, Harder D, Melter M, et al. Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol. 2008;103:712-719.
70. Meyers RL, Book LS, O'Gorman MA, et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg. 2003;38:406-411.
71. Escobar MA, Jay CL, Brooks RM, et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg. 2006;41:99-103.
72. Dillon PW, Owings E, Cilley R, et al. Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg. 2001;36:80-85.
73. Davenport M, Stringer MD, Tizzard SA, et al. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology. 2007;46:1821-1827.
74. Davenport M, Parsons C, Tizzard S, et al. Steroids in biliary atresia: single surgeon, single centre, prospective study. J Hepatol. 2013;59:1054-1058.
75. Nio M, Muraji T; Japanese Biliary Atresia Society. Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia. Pediatr Surg Int. 2013;29:1091-1095.
76. Bezerra JA, Spino C, Magee JC, et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014;311:1750-1759.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台